Craig Stephen Hammes, MD | |
885 1650 Ln, Delta, CO 81416-8107 | |
(952) 595-1242 | |
(952) 935-2757 |
Full Name | Craig Stephen Hammes |
---|---|
Gender | Male |
Speciality | Radiology - Diagnostic Radiology |
Location | 885 1650 Ln, Delta, Colorado |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1639163843 | NPI | - | NPPES |
483724787 | Other | CHAMPUS | |
HAC2708 | Other | CO | BLUE CROSS BLUE SHIELD |
01325687 | Medicaid | CO | |
195679 | Medicaid | AZ | |
841184495001 | Other | CO | RMHP |
XPY185580 | Medicaid | CA |
Mailing Address | Practice Location Address |
---|---|
Craig Stephen Hammes, MD 11995 Singletree Ln, Suite 500, Eden Prairie, MN 55344-5347 Ph: (952) 595-1242 | Craig Stephen Hammes, MD 885 1650 Ln, Delta, CO 81416-8107 Ph: (952) 595-1242 |
News Archive
A team led by scientists at Cold Spring Harbor Laboratory (CSHL) publishes research today indicating a striking association between genes found disrupted in children with autism and genes that are targets of FMRP, the protein generated by the gene FMR1, whose dysfunction causes Fragile-X syndrome.
Mana Health's ManaPortal version 1.0.0, has achieved ONC HIT 2014 Edition Modular EHR certification, which designates that the software is capable of supporting eligible providers and hospitals with meeting the Stage 1 and Stage 2 Meaningful Use measures required to qualify for funding under the American Recovery and Reinvestment Act.
Inova Labs, Inc. of Austin, Texas announced today the closing of the private placement of shares of its Series A Preferred Stock. The placement went to investment funds affiliated with Three Arch Partners, based in Silicon Valley, California. Inova received gross proceeds of $10.0 million from the equity financing, which will be used for nationwide and international sales expansion of its LifeChoice® portable oxygen concentrator product line, continuation of next stage developments, and working capital.
The presence of multiple ovarian cancer genomes in an individual patient and the absence or downregulation of the gene LRP1B are associated with the development of chemoresistance in women with the high-grade serous cancer subtype of ovarian cancer whose disease recurs after primary treatment. These study results are published in Cancer Research, a journal of the American Association for Cancer Research.
› Verified 4 days ago
Steven M Bernstein, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1501 E 3rd St, Delta, CO 81416 Phone: 970-874-7681 | |
Paul Joseph Sheya, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 1501 E 3rd St, Delta, CO 81416 Phone: 970-874-7681 |